FGFR3/FGF9 Regulates the Activity of Profibrotic Cytokine and Growth Factor Pathways to Drive Fibroblast Activation and Tissue Fibrosis in Systemic Sclerosis

Summa L, Thuong Trinh-Minh , Chen CW, Soare A, Distler O, Schett G, Distler J, Chakraborty D, Ramming A (2018)

Publication Type: Conference contribution

Publication year: 2018

Journal

Arthritis and Rheumatology Wiley

Book Volume: 70

Authors with CRIS profile

Georg Schett Lehrstuhl für Innere Medizin III Jörg Distler Professur für Molekulare Mechanismen der Organfibrose Debomita Chakraborty Department of Medicine 3 – Rheumatology and Immunology Andreas Ramming Department of Medicine 3 – Rheumatology and Immunology

Involved external institutions

Universitätsspital Zürich (USZ) CH Switzerland (CH)

How to cite

APA:

Summa, L., Thuong Trinh-Minh, ., Chen, C.-W., Soare, A., Distler, O., Schett, G.,... Ramming, A. (2018). FGFR3/FGF9 Regulates the Activity of Profibrotic Cytokine and Growth Factor Pathways to Drive Fibroblast Activation and Tissue Fibrosis in Systemic Sclerosis.

MLA:

Summa, Lena, et al. "FGFR3/FGF9 Regulates the Activity of Profibrotic Cytokine and Growth Factor Pathways to Drive Fibroblast Activation and Tissue Fibrosis in Systemic Sclerosis." 2018.

BibTeX: Download